AVELOS THERAPEUTICS
Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics.
AVELOS THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Precision Medicine
Founded:
2021-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.avelostx.com
Total Employee:
11+
Status:
Active
Total Funding:
20.43 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 50m
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโbased treatments for cardiovascular disease.
Vittoria Biotherapeutics
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Investors List
Medytox Venture Investment
Medytox Venture Investment investment in Series B - Avelos Therapeutics
Shinhan Capital
Shinhan Capital investment in Series B - Avelos Therapeutics
LSK Investment
LSK Investment investment in Series B - Avelos Therapeutics
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series B - Avelos Therapeutics
Stassets Investment
Stassets Investment investment in Series B - Avelos Therapeutics
SV Investment Corp
SV Investment Corp investment in Series B - Avelos Therapeutics
Heungkuk Asset Management
Heungkuk Asset Management investment in Series B - Avelos Therapeutics
Quad Asset Management
Quad Asset Management investment in Series B - Avelos Therapeutics
Timepolio Asset Management
Timepolio Asset Management investment in Series B - Avelos Therapeutics
UTC Investment Co.
UTC Investment Co. investment in Series A - Avelos Therapeutics
Official Site Inspections
http://www.avelostx.com
- Host name: 58.230.162.233
- IP address: 58.230.162.233
- Location: Daegu South Korea
- Latitude: 35.8723
- Longitude: 128.5924
- Timezone: Asia/Seoul
- Postal: 41934
More informations about "Avelos Therapeutics"
AVELOS Therapeutics
Address #325, 21 Magokjungang 8-ro 7-gil, Gangseo-gu, Seoul, Republic of Korea ์์ธํน๋ณ์ ๊ฐ์๊ตฌ ๋ง๊ณก์ค์8๋ก7๊ธธ 21 325ํธ TEL +82-2-6949-4369See details»
Avelos Therapeutics - Crunchbase Company Profile & Funding
Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics.See details»
Avelos Therapeutics Company Profile 2024: Valuation, โฆ
Avelos Therapeutics General Information Description. Developer of biomarker-driven anti-cancer targeted therapies intended for cancer treatment. The โฆSee details»
Avelos Therapeutics Inc. - Overview, News & Similar ... - ZoomInfo
View Avelos Therapeutics Inc. (www.avelostx.com) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
Avelos Therapeutics - Company Profile - Tracxn
Oct 13, 2024 Avelos Therapeutics ranks 75th among 432 active competitors. 147 of its competitors are funded while 93 have exited. Overall, Avelos Therapeutics and its competitors โฆSee details»
Avelos Therapeutics - LinkedIn
Avelos Therapeutics | 308 followers on LinkedIn. Strive for a Better Tomorrow. | Avelos Therapeutics develops next-generation targeted oncology medicines with high unmet need, to a wider range of ...See details»
AVELOS Therapeutics
Young-Whan Park Ph.D. Chief Executive Officer. Dr. Young-Whan Park brings 30 years of global pre-clinical and clinical drug R&D experience. Dr. Park previously worked as a president of National OncoVenture (NOV), a Korean government โฆSee details»
Avelos Therapeutics - VentureRadar
Similar Companies: Website: http://avelostx.com/ Develops oncology drugs, with a focus on synthetic lethality, DNA damage response, and cell cycle regulation.See details»
Nextsource | Company Profile | Avelos Therapeutics
Explore the company profile of Avelos Therapeutics (avelostx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Avelos Therapeutics - VentureRadar
Website: http://avelostx.com/ Develops innovative oncology treatments through research and development, focusing on small molecule drugs targeting synthetic lethality ...See details»
Media - avelostx.com
To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics. Avelos Therapeutics is a specialized research and development (R&D) company focused on oncology โฆSee details»
AD-1208 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics Avelos Therapeutics is a specialized research and development (R&D) company โฆSee details»
Avelos Therapeutics (Avelos Therapeutics) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ โฆ
To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics Avelos Therapeutics is a specialized research and development (R&D) company focused on oncology โฆSee details»
AVELOS THERAPEUTICS ANNOUNCES KRW 17 BILLION SERIES B โฆ
May 29, 2024 Avelos Therapeutics, a leading innovator in the development of novel anti-cancer drugs, recently completed a successful Series B funding round totaling KRW 17 billion โฆSee details»
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A โฆ
Aug 22, 2022 To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics . Avelos Therapeutics is a specialized research and development (R&D) โฆSee details»
AVELOS THERAPEUTICS ANNOUNCES KRW 17 BILLION SERIES B โฆ
May 29, 2024 To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics . Avelos Therapeutics is a specialized research and development (R&D) โฆSee details»
Avelos Therapeutics Announces KRW 17 Billion Series B ... - BioSpace
May 29, 2024 To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics . Avelos Therapeutics is a specialized research and development (R&D) โฆSee details»
AVS-1001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 To learn more about Avelos Therapeutics, visit avelostx.com. About Avelos Therapeutics Avelos Therapeutics is a specialized research and development (R&D) company โฆSee details»
Company Introduction (Video) : 2023 Global VC Connect 365
Address #325, 21 Magokjungang 8-ro 7-gil, Gangseo-gu, Seoul, Republic of Korea ์์ธํน๋ณ์ ๊ฐ์๊ตฌ ๋ง๊ณก์ค์8๋ก7๊ธธ 21 325ํธ TEL +82-2-6949-4369See details»
Research - AVELOS Therapeutics
Cell Cycle & Checkpoints. Cell growth and division are tightly controlled by cell cycle checkpoints to maintain genome stability and integrity. However, these processes are defective in cancers โฆSee details»